Biotech Firm eXoZymes Secures US Funding to Create Virtual Models of Biological Manufacturing
Wageningen, Friday 24 July 2026
Partnering with a top US national laboratory, eXoZymes is utilising AI digital twins to simulate and optimise biological manufacturing, bypassing traditional, unpredictable living-cell variables.